ZEMCRO

Welcome to the Brand page for “ZEMCRO”, which is offered here for Pharmaceutical preparations, immunotherapeutic and immunosuppressive preparations for medical use for treatment of transplantation patients; pharmaceutical modified release systems, and controlled release systems, comprised of tablets, granules, pills, sachets, powders, capsules, solutions or fluids, all of the above for use in the treatment of mental and physical disorders, traumas and emergencies, addictions, aging, allergy/immunology, burns, diseases of the heart and blood vessels, dental and gum diseases, skin diseases, nutritional and dietary diseases, diseases of the endocrinological system and pancreatic diseases, diabetes, epidemical diseases, diseases and afflictions of the gastroenterological system, diseases of the blood, infectious diseases, neurological diseases, nephrological diseases, diseases in the obstetrical and gynecological field, cancer, ophthalmological diseases, diseases and afflictions affecting the bones, joints, cartilage material and muscles, diseases and afflictions of the ear, nose and throat, diseases and afflictions in the psychiatric field, pulmonological diseases and afflictions, rheumatism, urological diseases and afflictions and generalised pain; veterinary preparations;medical and pharmaceutical assistance, consultation and information services, regarding immunotherapeutic and immunosuppressive preparations and treatment;.

Its status is currently believed to be active. Its class is unavailable. “ZEMCRO” is believed to be currently owned by “VELOXIS PHARMACEUTICALS A/S”.